The Management of Hypertension in the Overweight and Obese Patient
- 1 January 2004
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 64 (8) , 795-803
- https://doi.org/10.2165/00003495-200464080-00001
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Sibutramine: its mode of action and efficacyInternational Journal of Obesity, 2002
- Choice of drug treatment for obesity-related hypertension: where is the evidence?Journal Of Hypertension, 2001
- Chronotherapeutic delivery of verapamil in obese versus non-obese patients with essential hypertensionJournal of Human Hypertension, 2001
- Insulin Sensitivity in Obese Hypertensive Dyslipidemic Patients Treated with Enalapril or AtenololJournal of Cardiovascular Pharmacology, 1995
- Body fat as a predictor of the antihypertensive effect of nifedipineJournal of Internal Medicine, 1995
- Obesity, the sympathetic nervous system, and essential hypertension.Hypertension, 1992
- Doxazosin effects on insulin and glucose in hypertensive patientsAmerican Heart Journal, 1991
- A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with HypertensionNew England Journal of Medicine, 1989
- Antihypertensive effect of diet compared with drug treatment in obese men with mild hypertension.BMJ, 1989